![](/img/cover-not-exists.png)
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
Ko, A H, Tempero, M A, Shan, Y-S, Su, W-C, Lin, Y-L, Dito, E, Ong, A, Wang, Y-W, Yeh, C G, Chen, L-TVolume:
109
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2013.408
Date:
August, 2013
File:
PDF, 554 KB
english, 2013